ATE305311T1 - Zusammensetzung zur behandlung von herzinsuffizienz - Google Patents

Zusammensetzung zur behandlung von herzinsuffizienz

Info

Publication number
ATE305311T1
ATE305311T1 AT01911868T AT01911868T ATE305311T1 AT E305311 T1 ATE305311 T1 AT E305311T1 AT 01911868 T AT01911868 T AT 01911868T AT 01911868 T AT01911868 T AT 01911868T AT E305311 T1 ATE305311 T1 AT E305311T1
Authority
AT
Austria
Prior art keywords
composition
disorders
heart failure
viral
heart disorders
Prior art date
Application number
AT01911868T
Other languages
English (en)
Inventor
Pal Aukrust
Stig Froland
Svein Simonsen
Halfdan Aass
Jan Fjeld
Arne Andreassen
Halfdan Ihlen
John Kjekshus
Sigurd Nitter-Hauge
Thor Ueland
Lars Gullestad
Egil Lien
Original Assignee
Medinnova As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0005867.7A external-priority patent/GB0005867D0/en
Priority claimed from GB0027661A external-priority patent/GB0027661D0/en
Application filed by Medinnova As filed Critical Medinnova As
Application granted granted Critical
Publication of ATE305311T1 publication Critical patent/ATE305311T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT01911868T 2000-03-10 2001-03-09 Zusammensetzung zur behandlung von herzinsuffizienz ATE305311T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0005867.7A GB0005867D0 (en) 2000-03-10 2000-03-10 Method
GB0027661A GB0027661D0 (en) 2000-11-13 2000-11-13 Method
PCT/GB2001/001054 WO2001066124A2 (en) 2000-03-10 2001-03-09 Composition for the treatment of heart failure

Publications (1)

Publication Number Publication Date
ATE305311T1 true ATE305311T1 (de) 2005-10-15

Family

ID=26243851

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01911868T ATE305311T1 (de) 2000-03-10 2001-03-09 Zusammensetzung zur behandlung von herzinsuffizienz

Country Status (8)

Country Link
EP (1) EP1267905B1 (de)
JP (1) JP2003525905A (de)
AT (1) ATE305311T1 (de)
AU (1) AU4079001A (de)
CA (1) CA2400504A1 (de)
DE (1) DE60113664T2 (de)
NO (1) NO20024289L (de)
WO (1) WO2001066124A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR101600A0 (en) * 2000-10-25 2000-11-16 Atheromastat Pty Ltd Compositions and methods for diagnosis and treatment of cardiovascular disorders
AUPS194902A0 (en) * 2002-04-24 2002-06-06 Atheromastat Pty Ltd Compositions and methods for diagnosis and treatment of cardiovascular disorders
US20030223985A1 (en) * 2002-05-29 2003-12-04 The Lauridsen Group. Incorporated Globulin protein to lower cholesterol in humans
EP1755642B1 (de) * 2004-04-15 2010-01-13 Athera Biotechnologies Ab Annexin zur prävention von der ruptur des plaques
US8025634B1 (en) * 2006-09-18 2011-09-27 Baxter International Inc. Method and system for controlled infusion of therapeutic substances
GB0717637D0 (en) 2007-09-10 2007-10-17 Univ Leiden Future cardiac event biomarkers
AU2008300516A1 (en) * 2007-09-20 2009-03-26 Bracco Imaging Spa Method for the preparation of new oligoclonal antibodies
EP2230251A1 (de) * 2009-03-19 2010-09-22 Bracco Imaging S.p.A Antikörper, die speziell im Koronarplaque aktiv sind und Verfahren zur ihrer Identifizierung
WO2013148708A1 (en) 2012-03-26 2013-10-03 Xcellcure, Llc Device and method for detection of analytes
US10087238B2 (en) 2017-02-22 2018-10-02 Kuwait University Method of preventing myocardial reperfusion injury in reperfusion therapy by administering intravenous immunoglobulin
KR102549282B1 (ko) * 2019-11-18 2023-06-30 건국대학교 산학협력단 시알산화된 면역글로불린을 유효성분으로 포함하는 염증성 질환의 치료용 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800078A (en) * 1987-05-28 1989-01-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Immunotherapeutic method of treating respiratory disease by intranasal administration of Igb
WO1994028932A1 (en) * 1993-06-11 1994-12-22 Sangstat Medical Corporation Immunoglobulin infusion in xenotransplantation
US5562902A (en) * 1994-03-14 1996-10-08 Arp Biomed, Inc. Immunotherapeutic method of treating cancerous diseases by administration of intravenous immunoglobulin
IL140155A (en) * 1998-06-09 2005-12-18 Statens Seruminstitut Process for producing immunoglobulins for intravenous administration and other immunoglobulin products

Also Published As

Publication number Publication date
WO2001066124A2 (en) 2001-09-13
AU4079001A (en) 2001-09-17
NO20024289D0 (no) 2002-09-09
DE60113664D1 (de) 2006-02-09
EP1267905A2 (de) 2003-01-02
WO2001066124A3 (en) 2002-03-28
JP2003525905A (ja) 2003-09-02
CA2400504A1 (en) 2001-09-13
DE60113664T2 (de) 2006-07-06
EP1267905B1 (de) 2005-09-28
NO20024289L (no) 2002-11-11

Similar Documents

Publication Publication Date Title
NO961326D0 (no) Inhibitorer av
ATE403430T1 (de) Neue carbamate- und harnstoffderivate als mittel gegen multidrugresistenz
DE69837324D1 (de) Behandlung der multiplen sklerose durch einnahme von copolymer-1
TNSN00010A1 (fr) DIPHENYLUREE A SUBSTITUTION ω CARBOXYARYLE SERVANT D'INHIBUTEURS DE RAF KINASE.
DE60114994D1 (de) Blutplättchen-adp-rezeptor-inhibitoren
ATE218854T1 (de) Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin- abhängigen protein kinase
WO2003037271A3 (en) Compounds, pharmaceutical compositions and methods of use therefor
BRPI0418112A (pt) inibidores de p-38 quinase bicìclico heterocìclicos
ATE318601T1 (de) Zusammensetzungen zur behandlung des schnupfens, welche ipratropium und xylometazolin enthalten
PT705100E (pt) Guanidinas substituidas terapeuticas
DE60113664D1 (de) Zusammensetzung zur behandlung von herzinsuffizienz
EA200301195A1 (ru) Применение энантиомерно чистого эсциталопрама
DK0804252T3 (da) Monoamin-, diamid-, thiol-holdige metalchelateringsmidler
PT1109571E (pt) Metodos de tratamento da hipertensao e composicoes para utilizacao nesses metodos
BG100930A (bg) Фармацевтични състави и лекарствени средства за профилактика и лечение на ендотелиални нарушения
ATE348812T1 (de) Chinolin- und chinazolinderivate als antagonisten des corticotropin freisetzenden faktors (crf)
DE69838882D1 (de) Pharmazeutisch wirksame verbindungen und methoden zu ihrer anwendung
EA200000242A1 (ru) Применение фанхинона для лечения болезни альцгеймера
RU96120655A (ru) Композиция для профилактики и лечения гриппа и орви
DK1303294T3 (da) Fremgangsmåde til behandling af instabil angina pectoris
BR9909971A (pt) Uso de um composto, processo para tratamento ou prevenção da sìndrome de intestinos irritáveis, e, composição farmacêutica para o tratamento da sìndrome dos intestinos irritáveis
ATE297211T1 (de) Verfahren und zusammensetzung zur behandlung von adenovirale augeninfektionen
BG105984A (bg) Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението
DE60011601D1 (de) Rekombinantes sp-a zur behandlung und vorbeugung von pulmonaren infektionen und entzündungen
BR0013665A (pt) Uso de uma proteìna histacalina, composição farmacêutica, e, método de tratar ou impedir conjuntivite

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties